In vivo CAR-T therapies dominate talks at ASGCT 2026 conference
read at Endpoints ↗Neutral
The reporter is on the ground in Boston covering the American Society of Gene & Cell Therapy's annual meeting.
Sessions across the conference are highlighting in vivo CAR-T approaches, showing that the technology is a central topic of discussion.
Developers of genetic medicines are still working to recover from recent setbacks, making the focus on in vivo CAR-T especially noteworthy.
The meeting serves as a platform for sharing data and perspectives on these emerging therapies.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “#ASGCT26 dispatch: In vivo CAR-T is everywhere”
read at Endpoints ↗90 words · retrieved May 14
comments(0)
5-min edit window · permanent after that